Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature

[1]  Rizwan Kalani,et al.  Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association , 2022, Circulation.

[2]  D. Kirk,et al.  Acute ST-elevation myocardial infarction in two young women with cystic fibrosis and cystic fibrosis-related diabetes , 2021, Journal of Cystic Fibrosis.

[3]  A. Thiagalingam,et al.  Azithromycin and tezacaftor/ivacaftor is associated with first-degree heart block in an adult with cystic fibrosis. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  A. Moran,et al.  Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[5]  C. Teneback,et al.  Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial , 2019, The Lancet.

[6]  L. Lands,et al.  Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. , 2019, The New England journal of medicine.

[7]  B. Quon,et al.  Safety and effectiveness of lumacaftor-ivacaftor in adults with cystic fibrosis: A single-center Canadian experience , 2019, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

[8]  C. Goss,et al.  Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study. , 2017, The Lancet. Respiratory medicine.

[9]  R. Levy,et al.  Coronary artery disease in cystic fibrosis: An emerging concern? , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[10]  S. Somerset,et al.  Dietary intake and nutritional status of micronutrients in adults with cystic fibrosis in relation to current recommendations. , 2016, Clinical nutrition.

[11]  Xiaohong Huang,et al.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.

[12]  K. Dwan,et al.  Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. , 2015, The Cochrane database of systematic reviews.

[13]  A. Moran,et al.  Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex. , 2015, American journal of respiratory and critical care medicine.

[14]  B. Morrissey,et al.  Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis. , 2014, Free radical biology & medicine.

[15]  刘欣,et al.  Clinical care guidelines for cystic fibrosis-related diabetes:a position statement of the Americal Diabetess Association and a clinical practice guideline of the Cystic Fibrosis Foundation ,endorsed by the pedistric Endocrine Society , 2011 .

[16]  K. Robinson,et al.  Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes , 2010, Diabetes Care.

[17]  F. Perrin,et al.  Ischaemic heart disease - a new issue in cystic fibrosis? , 2010, Journal of the Royal Society of Medicine.

[18]  G. Onady,et al.  An adult cystic fibrosis patient presenting with persistent dyspnea: case report , 2006, BMC pulmonary medicine.

[19]  R. Heine,et al.  Clinical significance of the physicochemical properties of LDL in type 2 diabetes , 2005, Diabetologia.

[20]  E. Parks,et al.  Abnormal lipid concentrations in cystic fibrosis. , 2002, The American journal of clinical nutrition.

[21]  K. Webb,et al.  The heart in cystic fibrosis. , 2002, Journal of the Royal Society of Medicine.

[22]  S. Bell,et al.  Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. , 2000, JOP : Journal of the pancreas.

[23]  Daniel Levy,et al.  Lifetime risk of developing coronary heart disease , 1999, The Lancet.

[24]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.